GlassScriptPhysician profile
Lori S James
NPI 1114065398
$3,239.14
in general payments reported to CMS, 2019-2025
38 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,641 · 2022: $530 · 2023: $325 · 2024: $437 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,068.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $594.94 | 2021-2025 | |
| Novo Nordisk INC | $347.26 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $235.98 | 2021-2022 | |
| Glaxosmithkline, LLC. | $234.47 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $192.65 | 2021-2025 | Otezla, Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $155.99 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $110.26 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $100.52 | 2021-2022 | |
| Esperion Therapeutics, INC. | $86.79 | 2021-2022 | |
| Abbott Laboratories | $83.65 | 2021 | |
| Exact Sciences Corporation | $82.59 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $78.88 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $77.00 | 2021-2022 | |
| Lilly USA, LLC | $71.86 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| E.R. Squibb & Sons, L.L.C. | $65.67 | 2021-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.